Bob Soh - Profile and Investment Details

Investor Profile

Bob Soh is a Venture Capital, Private Equity Firm, Investor based in Melbourne, Victoria, Australia with a diverse investment portfolio that includes companies such as QUE Oncology, Glyscend, Elastagen, Denteric, EBR Systems, Inc., MecRx, Spinifex Pharmaceuticals, Glyscend Incorporated, Heart Metabolics, PolyActiva, Cardiora, Q-Sera, Okogen, Ena Respiratory, G I Therapies, Protego Medical, Vaxxas, Myricx PharmaSignostics, EBR Systems, Auspherix, Solvanix, MetaBloQ, OccuRx, Global Kinetics Corporation, Aravax, Fibrotech Therapeutics, . Over time, Bob Soh has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Bob Soh is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Drug Discovery, Wellness, Life Science, Engineering, Education, Biotechnology, Drug Development, Health and Hospital Services, Neuroscience, Research, Health Diagnostics, Medical, B2B, Therapeutics, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Bob Soh, as their portfolio suggests a familiarity and interest in this area.

Understanding Bob Soh’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.